Johnson & Johnson (JNJ) Prepaid Assets (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Prepaid Assets came in at $4.8 billion in Q2 2026, up 10.69% year-over-year from $4.4 billion in Q2 2025, and little changed quarter-over-quarter from $4.8 billion in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Prepaid Assets (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Prepaid Assets across 18 years of filings, most recently posting $4.8 billion for Q2 2026.
- In Q2 2026, Prepaid Assets rose 10.69% year-over-year to $4.8 billion; the TTM figure through Jun 2026 stood at $4.8 billion (up 10.69% YoY), while the FY2025 annual figure was $4.2 billion, up 1.66% from the prior year.
- Prepaid Assets came in at $4.8 billion for Q2 2026 at Johnson & Johnson, roughly flat from $4.8 billion in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $4.8 billion in Q2 2026 to a low of $2.4 billion in Q3 2023.
- Average Prepaid Assets over 5 years is $3.9 billion, with a median of $4.2 billion recorded in 2025.
- Year-over-year, Prepaid Assets tumbled 35.27% in 2023 and surged 82.69% in 2024.
- Over 5 years, Prepaid Assets stood at $3.6 billion in 2022, then advanced by 25.67% to $4.5 billion in 2023, then dropped by 9.5% to $4.1 billion in 2024, then increased by 1.66% to $4.2 billion in 2025, then increased by 16.21% to $4.8 billion in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $4.8 billion in Q2 2026, $4.8 billion in Q1 2026, and $4.2 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 4.83 Bn |
| Mar 29, 2026 | 4.82 Bn |
| Dec 28, 2025 | 4.15 Bn |
| Sep 28, 2025 | 4.29 Bn |
| Jun 29, 2025 | 4.36 Bn |
| Mar 30, 2025 | 4.09 Bn |
| Dec 29, 2024 | 4.09 Bn |
| Sep 29, 2024 | 4.18 Bn |
| Jun 30, 2024 | 4.38 Bn |
| Mar 31, 2024 | 4.46 Bn |
| Dec 31, 2023 | 4.51 Bn |
| Oct 1, 2023 | 4.20 Bn |
| Jul 2, 2023 | 2.40 Bn |
| Apr 2, 2023 | 2.92 Bn |
| Jan 1, 2023 | 2.88 Bn |
| Oct 2, 2022 | 3.59 Bn |
| Jul 3, 2022 | 3.70 Bn |
| Apr 3, 2022 | 3.45 Bn |
| Jan 2, 2022 | 3.70 Bn |
| Oct 3, 2021 | 3.59 Bn |